Uric acid secretion from adipose tissue and its increase in obesity
about
Linking uric acid metabolism to diabetic complicationsAdipose tissue as an immunological organRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisAnti-Diabetic Activity and Metabolic Changes Induced by Andrographis paniculata Plant Extract in Obese Diabetic Rats.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in micePositive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice.Association of Serum Uric Acid with Body Mass Index: A Cross-Sectional Study from Jiangsu Province, China.Association of Elevated Serum Uric Acid with the Components of Metabolic Syndrome and Oxidative Stress in Abdominal Obesity Subjects[The role of uric acid in the insulin resistance in children and adolescents with obesity].Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.Mechanisms of spontaneous resolution of acute gouty inflammation.Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue: IN VIVO METABOLIC TURNOVER ANALYSIS.Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.Metabolomic Profiling of Long-Term Weight Change: Role of Oxidative Stress and Urate Levels in Weight Gain.Association between serum uric acid and metabolic syndrome components in prepubertal obese children (Tanner Stage I) from Nuevo León, Mexico - a preliminary study.Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.Visceral fat mass: is it the link between uric acid and diabetes risk?Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypesThe xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid.Gender-related association between uric acid, homocysteine, γ-glutamyltransferase, inflammatory biomarkers and metabolic syndrome in subjects affected by obesity.Dietary Salba (Salvia hispanica L.) ameliorates the adipose tissue dysfunction of dyslipemic insulin-resistant rats through mechanisms involving oxidative stress, inflammatory cytokines and peroxisome proliferator-activated receptor γ.Anti-hyperuricemic effect of taxifolin in cultured hepatocytes and model mice.The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.Nociceptive Alteration by High Sucrose Diet in Hypoestrogenic Wistar Rats.Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women.Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients(Pall.) Kuntze (New Zealand Spinach) Prevents Obesity and Hyperuricemia in High-Fat Diet-Induced Obese MiceUric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting
P2860
Q26996416-2974ABBE-DAD0-4C72-ACA7-81559702224DQ27003461-C713B4B9-E559-4C34-9827-E231682D124EQ28354735-E932D358-FC48-4055-ABF5-2F8DDC6CE01BQ31121319-1C384B11-19A1-425E-BC95-DC0A39FC9824Q33683082-E7AC889F-7D4C-47AC-8B82-5C17C6E254B0Q35088793-372D7EF2-2397-43CD-A82F-F2DC6C17280DQ35666688-703056EF-9F3E-4C3A-A820-312256698702Q35747103-33C873E5-4AC2-4A74-87B4-C1CD390CF02AQ36388665-06AA23A3-80DC-4B10-8F56-FC115E4DDFB0Q37447055-EC20A8A7-1D39-4E09-8CAC-F2ADA22E6674Q38171695-B67DBFB4-6928-4691-8E44-C16CE2195E8CQ39001133-C619C3D4-3446-4B0E-AD43-04F990E79702Q39200510-BA42D95E-013F-44D8-B8E2-C78A67623A82Q40101729-AB52BCD9-B9AD-4A02-9BCC-452C0FCA5DE8Q40968368-FED3E9BB-6116-4B33-963D-5976028690BAQ41070039-BD245313-6CBE-4499-ADFC-CC18B56D7DE7Q41111751-22268838-594D-4C16-B2FD-72DFA139CAB4Q41460300-9B59D6FD-C6BB-4298-AA1E-65CD5556CA0EQ41634439-8F30116C-1456-4B07-99BA-F34F61BC5412Q42363114-C09D1EAF-C682-4A4D-887F-E1E0E4BEC3BFQ42376724-67B391FA-29A8-4398-B7C8-9D995C10B8CAQ47604158-08881F00-E592-40A6-AFEA-6681A5F487A3Q48092341-8A7B9F93-84A4-401C-845F-D5B2BB23C1FEQ48336999-977427CA-F586-4284-8F97-B56D4A46BD97Q52941618-51685FB4-6B12-49AD-83B9-D9B9C4E8FB37Q53056509-DFCCA54D-CCB2-4C7E-B419-C750CD71F63AQ53688741-91813B6D-D002-4499-8CEE-5FF9E754FFDCQ55065528-42E07EF3-8179-4177-A159-F16663C412A8Q57823822-DC77B178-61A6-40A0-BE97-3C4B12147A64Q58780320-7B37E0F6-D582-4FBD-A922-73C0E6DBB05FQ58795687-F63A4442-442F-4BBB-BABA-A7682BD9F99E
P2860
Uric acid secretion from adipose tissue and its increase in obesity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uric acid secretion from adipose tissue and its increase in obesity
@en
Uric acid secretion from adipose tissue and its increase in obesity.
@nl
type
label
Uric acid secretion from adipose tissue and its increase in obesity
@en
Uric acid secretion from adipose tissue and its increase in obesity.
@nl
prefLabel
Uric acid secretion from adipose tissue and its increase in obesity
@en
Uric acid secretion from adipose tissue and its increase in obesity.
@nl
P2093
P2860
P356
P1476
Uric acid secretion from adipose tissue and its increase in obesity
@en
P2093
Hideaki Nakatsuji
Hirofumi Nagao
Hiroyuki Takahashi
Hitoshi Nishizawa
Iichiro Shimomura
Keiichiro Imaizumi
Kenta Kato
Mizuho Tamura
Norikazu Maeda
Ryohei Sekimoto
P2860
P304
27138-27149
P356
10.1074/JBC.M113.485094
P407
P577
2013-08-02T00:00:00Z